OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.73 | Prev. Close $0.72 | Circuit Range N/A |
Day Range $0.70 - $0.76 | Year Range $0.47 - $12.54 | Volume 18,986 |
Average Traded $0.72 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jan-26 | $0.71 | $0.72 | -3.50% |
16-Jan-26 | $0.80 | $0.74 | -3.13% |
15-Jan-26 | $0.73 | $0.77 | +4.50% |
14-Jan-26 | $0.75 | $0.73 | -2.53% |
13-Jan-26 | $0.69 | $0.75 | +5.62% |
12-Jan-26 | $0.69 | $0.71 | +5.64% |
09-Jan-26 | $0.65 | $0.67 | +10.31% |